- Exchange: EN Paris
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Snapshot for Vetoquinol SA (VETO)
| Open: | 21.3500 | Day's Range: | 21.3500 - 21.3500 | Volume: | 42 | Bid: | 21.3500 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 21.5000 | 52wk Range: | 20.0600 - 30.2500 | 1-Yr Rtn: | -27.14% | Ask: | 21.5000 |
Key Statistics for VETO
| Current P/E Ratio (ttm) | 14.2144 |
|---|---|
| Estimated P/E (12/2012) | 11.5718 |
| Earnings Per Share (EUR) (ttm) | 1.5020 |
| Est. EPS (EUR) (12/2012) | 1.8450 |
| Est. PEG Ratio | - |
| Market Cap (M EUR) | 253.68 |
| Shares Outstanding (M) | 11.88 |
| Enterprise Value (M EUR) (ttm) | 249.02 |
| Enterprise Value/EBITDA (ttm) | 5.34 |
| Price/Book (mrq) | 1.2269 |
| Price/Sale (ttm) | 0.8859 |
| Dividend Indicated Gross Yield | 1.5457 |
| Next Earnings Announcement | 08/30/2012 |
More VETO Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for VETO
- Operating
- Investing
- Financing (M/EUR)
Company Profile & Key Executives for VETO
Vetoquinol S.A. is an independent veterinary pharmaceutical laboratory serving both the companion and production animal markets. The Company operates in the research and development, production and marketing of medical and non-medical products in areas such as anti-infectives, pain/inflammation and cardiology/ nephrology.
| Etienne FrechinChairman | Matthieu FrechinChief Executive Officer |
| Regis Vimal Du MonteilFinance Director |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page